(Q84040057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (the Novo Study) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

O Fernández

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

V Fernández

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

T Arbizu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

G Izquierdo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

I Bosca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

R Arroyo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

J A García Merino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

E de Ramón

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Novo Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

10 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1500-1507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20383518%20AND%20SRC:MED&resulttype=core&format=json

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

30 January 2020

cites work

1 reference

12 December 2020

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

12 December 2020

Longitudinal follow-up of "benign" multiple sclerosis at 20 years

1 reference

12 December 2020

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

1 reference

12 December 2020

Neurophysiological investigations in multiple sclerosis

1 reference

12 December 2020

The natural history of multiple sclerosis

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

Clinical predictors of early second event in patients with clinically isolated syndrome

1 reference

12 December 2020

International consensus statement on the use of disease-modifying agents in multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.

1 reference

12 December 2020

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review

1 reference

12 December 2020

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

1 reference

12 December 2020

1 reference

12 December 2020

Effective multiple sclerosis management through improved patient assessment.

1 reference

12 December 2020

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

12 December 2020

A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease

1 reference

12 December 2020

Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta

1 reference

12 December 2020

Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.

1 reference

12 December 2020

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

1 reference

12 December 2020

Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis

1 reference

12 December 2020

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

1 reference

12 December 2020

Epitope spreading: a mechanism for progression of autoimmune disease.

1 reference

12 December 2020

Cortical demyelination in CNS inflammatory demyelinating diseases

1 reference

12 December 2020

Evoked potentials in diagnosis and monitoring of multiple sclerosis

1 reference

12 December 2020

Natural history of multiple sclerosis

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

1 reference

12 December 2020

Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study

1 reference

12 December 2020

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

1 reference

12 December 2020

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

1 reference

12 December 2020

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

1 reference

12 December 2020

Early treatment of multiple sclerosis to prevent neurologic damage

1 reference

12 December 2020

The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds

1 reference

12 December 2020

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Treatment optimization in multiple sclerosis

1 reference

12 December 2020

B cells and multiple sclerosis

1 reference

12 December 2020

Benign multiple sclerosis: some recent ideas

1 reference

12 December 2020

[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)]

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Changes in the ascertainment of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis: an immune or neurodegenerative disorder?

1 reference

12 December 2020

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

12 December 2020

Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician

1 reference

12 December 2020

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis

1 reference

12 December 2020

Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein

1 reference

12 December 2020

Experiences of diagnosis and treatment among people with multiple sclerosis.

1 reference

12 December 2020

Disease-modifying therapy in multiple sclerosis: strategies for optimizing management

1 reference

12 December 2020

Predictive value of clinical characteristics for 'benign' multiple sclerosis

1 reference

12 December 2020

Natural history of multiple sclerosis: a unifying concept

1 reference

12 December 2020

Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients

1 reference

12 December 2020